Verano Holdings Corp ( VRNO) - Stock Earnings
VRNO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026, midnight | — / — | — | — / — | — |
VRNO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -21.7 million USD | 202.8 million USD |
| 2025Q4 | 532000 USD | 206.6 million USD |
| 2026Q1 | -590000 USD | 208.2 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
VRNO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -58.4 million USD | 938.5 million USD |
| 2024 | 11.1 million USD | 878.6 million USD |
| 2025 | -58.4 million USD | 821.5 million USD |
| 2026 Est. | — | — |
VRNO
Price: $5.55
52 week price:
Earnings Per Share: -0.99 USD
P/E Ratio: -1.08
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 419.1 million